Cargando…
Measurement of labile and protein-bound heme in fixed prostate cancer cells and in cellular fractions
Labile heme is present in the cells at very low concentrations, either unbound or loosely bound to molecules, and accessible for signaling as alarmin. Our recent work suggests that extracellular heme can be taken up and detected in the nuclei of cancer cells. Here, we describe the detailed protocol...
Autores principales: | Canesin, Giacomo, Janovicova, Lubica, Wegiel, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091920/ https://www.ncbi.nlm.nih.gov/pubmed/33997811 http://dx.doi.org/10.1016/j.xpro.2021.100491 |
Ejemplares similares
-
Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer
por: Hecht, Jonathan L., et al.
Publicado: (2022) -
Heme-Derived Metabolic Signals Dictate Immune Responses
por: Canesin, Giacomo, et al.
Publicado: (2020) -
Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases
por: Canesin, Giacomo, et al.
Publicado: (2020) -
Heme oxygenase-1 mitigates liver injury and fibrosis via modulation of LNX1/Notch1 pathway in myeloid cells
por: Canesin, Giacomo, et al.
Publicado: (2022) -
Free heme exacerbates colonic injury induced by anti-cancer therapy
por: Seika, Philippa, et al.
Publicado: (2023)